Status:
UNKNOWN
Early Detection of Respiratory Disorders in Psychosis
Lead Sponsor:
Fundación Marques de Valdecilla
Collaborating Sponsors:
Instituto de Investigación Marqués de Valdecilla
Consorcio Centro de Investigación Biomédica en Red (CIBER)
Conditions:
Schizophrenia
Psychosis
Eligibility:
All Genders
18-60 years
Brief Summary
This study aims to evaluate the presence of lung function impairment in a sample of patients diagnosed with non-affective psychosis.
Detailed Description
Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory disorders with high prevalence in the general population. Tobacco smoking is the leading risk factor for COPD, and has b...
Eligibility Criteria
Inclusion
- Patients followed in the First Episode Psychosis Clinical Program (PAFIP) from February 2001 to December 2007.
- Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria of brief psychotic disorder, schizophreniform disorder, schizophrenia or schizoaffective disorder.
Exclusion
- Meeting DSM-IV criteria for drug dependence.
- Meeting DSM-IV criteria for mental retardation.
- Having a history of neurological disease or head injury.
Key Trial Info
Start Date :
February 16 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03476473
Start Date
February 16 2018
End Date
December 1 2020
Last Update
December 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Marqués de Valdecilla
Santander, Cantabria, Spain, 39008